Cargando…

CYP3A genetic variation and taxane-induced peripheral neuropathy: a systematic review, meta-analysis, and candidate gene study

Background: Taxane-induced peripheral neuropathy (TIPN) is an important cause of premature treatment cessation and dose-limitation in cancer therapy. It also reduces quality of life and survivorship in affected patients. Genetic polymorphisms in the CYP3A family have been investigated but the findin...

Descripción completa

Detalles Bibliográficos
Autores principales:	McEvoy, Laurence, Cliff, Joanne, Carr, Daniel F, Jorgensen, Andrea, Lord, Rosemary, Pirmohamed, Munir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352989/ https://www.ncbi.nlm.nih.gov/pubmed/37469869 http://dx.doi.org/10.3389/fphar.2023.1178421

Ejemplares similares

Corrigendum: CYP3A genetic variation and taxane-induced peripheral neuropathy: a systematic review, meta-analysis, and candidate gene study
por: McEvoy, Laurence, et al.
Publicado: (2023)

Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity
por: McEvoy, L., et al.
Publicado: (2021)

Effect of Genetic Variability in the CYP4F2, CYP4F11, and CYP4F12 Genes on Liver mRNA Levels and Warfarin Response
por: Zhang, J. E., et al.
Publicado: (2017)

The impact of SBF2 on taxane-induced peripheral neuropathy
por: Cunningham, Geneva M., et al.
Publicado: (2022)

Cryotherapy for Prevention of Taxane-Induced Peripheral Neuropathy: A Meta-Analysis
por: Jia, Junting, et al.
Publicado: (2021)

Vincristine-Induced Peripheral Neuropathy in Childhood Acute Lymphoblastic Leukemia: Genetic Variation as a Potential Risk Factor
por: Yang, Qing-Yan, et al.
Publicado: (2021)

Efavirenz and Metabolites in Cerebrospinal Fluid: Relationship with CYP2B6 c.516G→T Genotype and Perturbed Blood-Brain Barrier Due to Tuberculous Meningitis
por: Nightingale, Sam, et al.
Publicado: (2016)

CYP2B6*18 is associated with nevirpine hypersensitivity independently of HLA-C*04:01 in a Malawian HIV population
por: Carr, Daniel, et al.
Publicado: (2014)

A Prospective Study of Taxane-Induced Neuropathy with Breast Cancer: Proper Assessment Tool for Taxane-Induced Neuropathy
por: Sohn, Eun Hee, et al.
Publicado: (2021)

Molecular mechanisms of genetic variation and transcriptional regulation of CYP2C19
por: Helsby, Nuala Ann, et al.
Publicado: (2012)

Investigating the Effect of Zinc on the Prevention of Acute Peripheral Neuropathy in Cancer Patients Treated with Taxanes
por: Haji Gholami, Ali, et al.
Publicado: (2022)

Ethnic Diversity and Warfarin Pharmacogenomics
por: Asiimwe, Innocent G., et al.
Publicado: (2022)

Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence
por: Fridley, Brooke L., et al.
Publicado: (2016)

Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN)
por: Han, Yaqin, et al.
Publicado: (2013)

Identifying Predictors of Taxane-Induced Peripheral Neuropathy Using Mass Spectrometry-Based Proteomics Technology
por: Chen, Emily I., et al.
Publicado: (2015)

Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
por: Molassiotis, Alex, et al.
Publicado: (2019)

Acupuncture for the Treatment of Taxane-Induced Peripheral Neuropathy in Breast Cancer Patients: A Pilot Trial
por: Jeong, Young Ju, et al.
Publicado: (2018)

Characterization of the genetic variation present in CYP3A4 in three South African populations
por: Drögemöller, Britt, et al.
Publicado: (2013)

CYP2D6 Genetic Variation and Its Implication for Vivax Malaria Treatment in Madagascar
por: Mehlotra, Rajeev K., et al.
Publicado: (2021)

The Protective Effect and Mechanism of Dexmedetomidine on Diabetic Peripheral Neuropathy in Rats
por: Zhang, Yan-zhuo, et al.
Publicado: (2020)

Advances About Immunoinflammatory Pathogenesis and Treatment in Diabetic Peripheral Neuropathy
por: Xue, Tianyu, et al.
Publicado: (2021)

Taxane-Induced Peripheral Neurotoxicity
por: Velasco, Roser, et al.
Publicado: (2015)

Assessment of Pharmacogenomic Panel Assay for Prediction of Taxane Toxicities: Preliminary Results
por: Di Francia, Raffaele, et al.
Publicado: (2017)

CYP2D7 Sequence Variation Interferes with TaqMan CYP2D6(*)15 and (*)35 Genotyping
por: Riffel, Amanda K., et al.
Publicado: (2016)

Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients’ Profiles With Oxaliplatin-Induced Peripheral Neuropathy
por: Kerckhove, Nicolas, et al.
Publicado: (2021)

Melatonin, a Promising Role in Taxane-Related Neuropathy
por: Nahleh, Z., et al.
Publicado: (2010)

Mechanism underlying linezolid-induced peripheral neuropathy in multidrug-resistant tuberculosis
por: Yuan, Yuan, et al.
Publicado: (2022)

Genetic variation in the 3′-UTR of CYP1A2, CYP2B6, CYP2D6, CYP3A4, NR1I2, and UGT2B7: potential effects on regulation by microRNA and pharmacogenomics relevance
por: Swart, Marelize, et al.
Publicado: (2014)

Charcot-Marie-Tooth gene, SBF2, associated with taxane-induced peripheral neuropathy in African Americans
por: Schneider, Bryan P., et al.
Publicado: (2016)

Safety and tolerability of cryocompression as a method of enhanced limb hypothermia to reduce taxane-induced peripheral neuropathy
por: Bandla, Aishwarya, et al.
Publicado: (2019)

A Multimodal Approach to Discover Biomarkers for Taxane-Induced Peripheral Neuropathy (TIPN): A Study Protocol
por: Sharma, Anukriti, et al.
Publicado: (2022)

Association of Taxane Type With Patient-Reported Chemotherapy-Induced Peripheral Neuropathy Among Patients With Breast Cancer
por: Mo, Hongnan, et al.
Publicado: (2022)

Characterization of complex structural variation in the CYP2D6-CYP2D7-CYP2D8 gene loci using single-molecule long-read sequencing
por: Turner, Amy J., et al.
Publicado: (2023)

Vitamin E for the Prevention of Chemotherapy-Induced Peripheral Neuropathy: A meta-Analysis
por: Chen, Jie, et al.
Publicado: (2021)

Taxane-induced sensory peripheral neuropathy is associated with an SCN9A single nucleotide polymorphism in Japanese patients
por: Tanabe, Yuko, et al.
Publicado: (2020)

Incidence density and factors associated with peripheral neuropathy among women with breast cancer during taxane-based chemotherapy
por: Rattanakrong, Nida, et al.
Publicado: (2022)

A preliminary, prospective study of peripheral neuropathy and cognitive function in patients with breast cancer during taxane therapy
por: Ibrahim, Eiman Y., et al.
Publicado: (2022)

A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancer
por: Mitin, Natalia, et al.
Publicado: (2022)

Diagnostic tools should be used for the diagnosis of chemotherapy induced peripheral neuropathy in breast cancer patients receiving taxanes
por: van Haren, Frank, et al.
Publicado: (2021)

Psychological distress and quality of life in breast cancer survivors with taxane-induced peripheral neuropathy: A scoping review
por: Schwab, Lauren, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3suk9e2jlg967csuophuhphe8t